Huynh Ronald, Sy Raymond W, Wong Stephen J, Wong Christopher C Y
Department of Cardiology, Concord Repatriation General Hospital, 1 Hospital Rd, Concord West, Sydney, New South Wales 2139, Australia.
Department of Cardiology, Royal Prince Alfred Hospital, 50 Missenden Rd, Camperdown, Sydney, NSW 2050, Australia.
Eur Heart J Case Rep. 2022 Feb 7;6(2):ytac047. doi: 10.1093/ehjcr/ytac047. eCollection 2022 Feb.
Eosinophilic myocarditis (EM) is a rare and devastating condition. The underlying cause of EM is unknown, and the natural history is not well understood.
A 20-year-old male presented in cardiogenic shock with preceding 24-h history of pleuritic chest pain associated with nausea and vomiting. Electrocardiogram showed sinus tachycardia with widespread ST elevation, significantly raised high-sensitivity troponin T, and raised white cell count with eosinophilia. Transthoracic echocardiogram demonstrated severe left ventricular (LV) impairment and a moderate-sized pericardial effusion. Right ventricular (RV) endomyocardial biopsy and bone marrow biopsy were performed, with both demonstrating prominent eosinophilia. He was initiated on pulse methylprednisolone leading to rapid clinical improvement with normalization of LV function. Day 9 after discharge, he was readmitted to hospital with presyncope and right heart failure. Electrocardiogram revealed junctional escape rhythm, and cardiac magnetic resonance imaging showed scarring confined to the atria. The patient was treated with mepolizumab and underwent an electrophysiology study with electroanatomical mapping, demonstrating sinus arrest and the absence of electrical activity throughout the right atrium. After much deliberation, an implantable cardioverter-defibrillator was implanted with a deep septal RV pacing lead and an apical RV defibrillator lead.
We present a unique case of EM with two distinct phases: the first marked by severe LV impairment resolving with immunosuppression; the second characterized by atrial cardiomyopathy leading to persistent symptomatic sinus arrest necessitating permanent pacing. Close follow-up of EM after initial remission is essential to monitor for further complications including heart failure and arrhythmias.
嗜酸性粒细胞性心肌炎(EM)是一种罕见且严重的疾病。EM的潜在病因尚不清楚,其自然病史也未得到充分了解。
一名20岁男性因心源性休克就诊,此前有24小时胸膜炎性胸痛病史,伴有恶心和呕吐。心电图显示窦性心动过速,广泛ST段抬高,高敏肌钙蛋白T显著升高,白细胞计数升高伴嗜酸性粒细胞增多。经胸超声心动图显示严重左心室(LV)功能损害和中等量心包积液。进行了右心室(RV)心内膜活检和骨髓活检,两者均显示明显的嗜酸性粒细胞增多。给予脉冲甲基强的松龙治疗后,临床症状迅速改善,LV功能恢复正常。出院后第9天,他因先兆晕厥和右心衰竭再次入院。心电图显示交界性逸搏心律,心脏磁共振成像显示瘢痕局限于心房。患者接受了美泊利珠单抗治疗,并进行了带有电解剖标测的电生理研究,显示窦性停搏且右心房无电活动。经过深思熟虑,植入了植入式心脏复律除颤器,带有深间隔RV起搏电极和心尖RV除颤电极。
我们报告了一例独特的EM病例,分为两个不同阶段:第一阶段以严重LV功能损害为特征,通过免疫抑制得以缓解;第二阶段以心房心肌病为特征,导致持续性症状性窦性停搏,需要永久起搏。EM初始缓解后密切随访对于监测包括心力衰竭和心律失常在内的进一步并发症至关重要。